Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.
He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.
He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.
Read moreProf. Dr. Serdar Bedii Omay is a respected hematologist. He specializes in Hematology and . He graduated from Hacettepe Medical School in 1985. He completed his Internal Medicine training at Ege University in 1990. He earned his PhD in Hematology at Japan Mie Medical School in 1995.
Dr. Omay has published 65 scientific articles, 112 meeting papers, and 34 international conference presentations. He has served as a professor at Ege University and Karadeniz Technical University. He also worked as a Hematology Specialist and Molecular Hematology Doctor in Japan. His career shows strong expertise and international recognition in his field.
Read moreDoctor's visit | price on request |
Chemotherapy | $1500 - $5000 |
Prof. Dr. Birol Baytan is a respected pediatric hematologist. He focuses on diagnosing and treating childhood cancers, leukemia, anemia, and bleeding disorders. He graduated from Ankara University Medical Faculty in 1992. He completed his specialization at Uludağ University Faculty of Medicine, Department of Child Diseases.
Prof. Baytan has published 15 articles in international journals. He has presented and published 9 full texts at international scientific meetings. He has contributed to 3 books or book chapters. He has also published 8 articles in local journals. These achievements show his strong academic presence in pediatric hematology.
Read moreDoctor's visit | price on request |
Chemotherapy | $1500 - $5000 |
Areas of Interest
Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist
Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department
Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis
Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain
Courses, Awards, and Certificates
1 Year of Work Certificate in , 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005
Research and Publications
Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.
Scientific Studies
A. Publications in International Journals under SCI Expanded
Turkish book section
1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.
2. Özen M, Ural AU. Hematological diseases and mesenchymal applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.
3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10
Read moreDr. Girish V. Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He has over 13 years of clinical experience. He treats leukemia, multiple myeloma, and performs s. Dr. Badarkhe has managed many complex cases with strong results.
He earned his MBBS from Grant Medical College. He completed his MD in Pathology at Lokmanya Tilak Municipal Medical College and his DM in Clinical Hematology at Medical College, Calcutta. Dr. Badarkhe has received several awards for his work and dedication in hematology-oncology.
Read moreDoctor's visit | price on request |
Immunotherapy with (Pembolizumab) | $3200 - $4000 |
Hematology oncologist, Head of the Hematology and Transplantation Center at Helios Berlin-Buch
Read moreDr. Siret Ratip is a hematologist and oncologist with over 25 years of clinical experience. He focuses on internal medicine and hematology. He has worked as an associate professor at respected institutions, including University College Hospital in London.
Dr. Ratip is a member of the British Hematology Committee and the Hematology Federation of Turkey. He has performed many advanced procedures, such as autologous and allogenic , aspiration, and biopsy. He has made important contributions to patient care and research in thalassemia.
Read moreDoctor's visit | price on request |
Chemotherapy for breast cancer | $8500 - $10000 |
Professor Jorg Groticke is the Chief Physician of the Oncology and Hematology Center at Bremen Mitte Hospital, specializing in the treatment of hematological malignancies and gastrointestinal tract tumors. He is a member of multiple medical organizations, and offers remote consultations for second opinions.
Read moreDoctor's visit | price on request |
Chemotherapy for breast cancer | $8500 - $10000 |
Pediatric hematologist-oncologist, specialist
Read moreProf. Dr. med. Ulrich Graven
Head of the Clinic of Hematology, Oncology and Gastroenterology
Head of a certified oncology center
Head of Clinical Research Department
Specialization:
Hematology, including transplantation
Abdominal oncology, especially colorectal and pancreatic cancer therapy
Metastasis therapy, including the use of off-label drugs
Membership in professional societies:
Professional Union of German Therapists
German Society for Internal Medicine
German Cancer Society
Abdominal Oncology Working Group
German Society of Hematology and Oncology
German Working Group on and Hematopoietic Cell Transplantation
German Society for Digestive and Metabolic Diseases
European Society for Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
Activities in professional communities:
German Cancer Society:
Since 2013, speaker of the commission for certification of oncology centers
Since November 2007, member of the board
Since September 2022, Speaker of the Section of National Societies on Cancer Control
Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.
Chairman of the Oncology Society of North Rhine-Westphalia.
Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.
Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.
Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.
Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.
Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.
Member of the committee for the development of clinical guidelines for colorectal cancer.
Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.
Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.
Read moreDr. Yener Koç is a specialist trained in the USA. He founded the Transplant Center at Medicana International Istanbul. Dr. Koç has performed more than 1,900 transplants. His patients have long-term survival rates of 66-90% for different blood disorders. He keeps mortality rates low, between 0.5-9%.
Dr. Koç has written over 230 scientific articles. Since 2004, he has served as a JACIE Accreditation Inspector for European Transplant Centers. He has received several awards, including the Outstanding Physician Award from Boston University and the International Healthcare Professional of the Year (UK).
Read moreDr. Prakash Pandit is an MD in Radiation Oncology and works as a Consultant. He has expertise in advanced cancer treatments. He specializes in Tomotherapy-H, Linear Accelerator, and Brachytherapy. He provides modern care for various types of cancer.
Dr. Pandit is known for his work in radiation oncology. He uses the latest technology to help patients. He has treated many complex cases. He always maintains high standards of safety and accuracy in his treatments.
Read moreDoctor's visit | price on request |
Immunotherapy with (Pembolizumab) | $3200 - $4000 |
Doctor's visit | price on request |
Immunotherapy with (Pembolizumab) | $3200 - $4000 |